镇静药物对重症患者睡眠结构的影响:基于比值比乘积的评估
结果显示,未镇静重症患者处于稳定睡眠(ORP<1.0)的时间比例显著低于正常睡眠者(31% vs 63%,p<0.001),大部分时间处于觉醒(ORP>1.75)或过渡状态(ORP 1.0-1.75)且觉醒侵入频繁。镇静后ORP分布显著向正常偏移:ORP<1.0比例增加54%(p=0.006),ORP>1.75比例减少48%(p=0.013)。丙泊酚与右美托咪定效果相当,但6例(26%)患者镇静未能改善睡眠。
要点
- 未镇静重症患者稳定睡眠(ORP<1.0)时间仅31%,显著低于正常睡眠者的63%(p<0.001),大部分时间处于觉醒或过渡状态。
- 丙泊酚或右美托咪定轻度镇静使ORP<1.0比例增加54%(p=0.006),ORP>1.75比例减少48%(p=0.013),睡眠结构向正常偏移。
- 丙泊酚与右美托咪定对睡眠结构的影响相当,但6例(26%)患者镇静未能改善睡眠。
- ORP是不依赖传统分期特征的连续睡眠深度指标(0=深睡,2.5=完全清醒),可用于重症患者睡眠评估。
适用人群与场景
- 镇静药物为丙泊酚(n=12)或右美托咪定(n=11)。
诊断标准与关键阈值
- 使用比值比乘积(ORP)评估睡眠深度:0=深睡,2.5=完全清醒。
- ORP<1.0定义为稳定睡眠,ORP>1.75定义为觉醒,ORP 1.0-1.75为过渡状态。
- 觉醒侵入定义为3秒ORP>1.75。
处置流程与药物剂量
- 原文未提及具体药物剂量、给药途径、频次或疗程。
- 仅提及使用丙泊酚或右美托咪定进行轻度镇静。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 未镇静重症患者ORP<1.0时间比例为31%,正常睡眠者为63%(p<0.001)。
- 镇静后ORP<1.0比例增加54%(p=0.006),ORP>1.75比例减少48%(p=0.013)。
- 丙泊酚与右美托咪定效果相当;6例(26%)患者镇静未改善睡眠。
证据类型、等级与局限
- 证据类型:回顾性研究。
对床旁实践的改变
- 对于稳定重症未镇静患者,应认识到其睡眠质量差、觉醒侵入频繁,不能仅凭传统评分判断。
- 轻度镇静(丙泊酚或右美托咪定)可能改善多数患者睡眠结构,但约26%患者无效,需个体化评估。
- ORP可作为重症患者睡眠评估的连续指标,但该研究为回顾性小样本,尚不能作为常规推荐依据。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Evaluation of sleep quality in critically ill patients is difficult using conventional scoring criteria. The aim of this study was to examine sleep in critically ill patients with and without light sedation using the odds ratio product, a validated continuous metric of sleep depth (0 = deep sleep; 2.5 = full wakefulness) that does not rely on the features needed for conventional staging.
DESIGN: Retrospective study.
SETTINGS: A 16-bed medical-surgical ICU.
PATIENTS: Twenty-three mechanically ventilated patients who had previously undergone two nocturnal sleep studies, one without and one with sedation (propofol, n = 12; dexmedetomidine, n = 11).
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Sleep architecture was evaluated with odds ratio product analysis by the distribution of 30-second epochs with different odds ratio product values. Electroencephalogram spectral patterns and frequency of wake intrusions (3-s odds ratio product > 1.75) were measured at different odds ratio product levels. Thirty-seven normal sleepers were used as controls. Compared with normal sleepers, unsedated critically ill patients spent little time in stable sleep (percent odds ratio product < 1.0: 31% vs 63%; p < 0.001), whereas most of the time were either in stage wake (odds ratio product > 1.75) or in a transitional state (odds ratio product 1.0-1.75), characterized by frequent wake intrusions. Propofol and dexmedetomidine had comparable effects on sleep. Sedation resulted in significant shift in odds ratio product distribution toward normal; percent odds ratio product less than 1.0 increased by 54% (p = 0.006), and percent odds ratio product greater than 1.75 decreased by 48% (p = 0.013). In six patients (26%), sedation failed to improve sleep.
CONCLUSIONS: In stable critically ill unsedated patients, sleep quality is poor with frequent wake intrusions and little stable sleep. Light sedation with propofol or dexmedetomidine resulted in a shift in sleep architecture toward normal in most, but not all, patients.
参考来源
- Georgopoulos D, Kondili E, Alexopoulou C, et al. Effects of Sedatives on Sleep Architecture Measured With Odds Ratio Product in Critically Ill Patients. Crit Care Explor. 2021. PMID: 34396142. doi:10.1097/CCE.0000000000000503
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。